Amphastar Pharmaceuticals reported earnings of $ 1.14 per AMPH share on Nov 5, 2026, beating analysts' expectations by
| Report Date | Nov 5, 2026 |
|---|---|
| Forecasted EPS | $ 0.859 |
| Earnings Per Share (Surprise) | $ 1.14 (+$ 0.281) |
| Last Year's EPS | $ 0.8125 |
| EPS YoY Change |
Out of the last 56 earnings reporting periods, Amphastar Pharmaceuticals beat analysts’ expectations 39 times and fell short of expectations 9 time(s). Amphastar Pharmaceuticals reported earnings per share of $ 1.14 in the last report surpassing an estimated EPS of $ 0.859 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 5, 2026 | $ 0.859 | $ 1.14 | $ 0.93 | |
| Aug 6, 2026 | $ 0.62 | $ 0.91 | $ 0.85 | |
| May 7, 2026 | $ 0.70 | $ 0.42 | $ 0.74 | |
| Feb 26, 2026 | $ 0.903 | $ 0.73 | $ 0.92 | |
| Nov 6, 2025 | $ 0.77 | $ 0.93 | $ 0.96 | |
| Aug 7, 2025 | $ 0.71 | $ 0.85 | $ 0.94 | |
| May 7, 2025 | $ 0.66 | $ 0.74 | $ 1.04 | |
| Feb 27, 2025 | $ 1.01 | $ 0.92 | $ 0.88 | |
| Nov 6, 2024 | $ 0.99 | $ 0.96 | $ 1.15 | |
| Aug 7, 2024 | $ 0.77 | $ 0.94 | $ 0.65 | |
| May 8, 2024 | $ 0.96 | $ 1.04 | $ 0.62 | |
| Feb 28, 2024 | $ 0.93 | $ 0.88 | $ 0.73 | |
| Nov 8, 2023 | $ 0.69 | $ 1.15 | $ 0.38 | |
| Aug 8, 2023 | $ 0.56 | $ 0.65 | $ 0.39 | |
| May 9, 2023 | $ 0.48 | $ 0.62 | $ 0.47 | |
| Feb 28, 2023 | $ 0.41 | $ 0.73 | $ 0.42 | |
| Nov 7, 2022 | $ 0.39 | $ 0.38 | $ 0.46 | |
| Aug 8, 2022 | $ 0.35 | $ 0.39 | $ 0.21 | |
| May 9, 2022 | $ 0.36 | $ 0.47 | $ 0.27 | |
| Mar 10, 2022 | $ 0.36 | $ 0.42 | $ 0.16 |
Amphastar Pharmaceuticals’s stock was trading at $ 28.02 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, AMPH’s price increased to $ 28.49 on Nov 6, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 5, 2026 | $ 1.14 | $ 28.02 | $ 28.49 | |
| Aug 6, 2026 | $ 0.91 | $ 20.24 | $ 20.78 | |
| May 7, 2026 | $ 0.42 | $ 23.90 | $ 19.00 | |
| Feb 26, 2026 | $ 0.73 | $ 27.97 | $ 20.23 | |
| Nov 6, 2025 | $ 0.93 | $ 25.31 | $ 24.03 | |
| Aug 7, 2025 | $ 0.85 | $ 20.82 | $ 23.81 | |
| May 7, 2025 | $ 0.74 | $ 23.87 | $ 24.65 | |
| Feb 27, 2025 | $ 0.92 | $ 31.21 | $ 28.43 | |
| Nov 6, 2024 | $ 0.96 | $ 51.56 | $ 46.09 | |
| Aug 7, 2024 | $ 0.94 | $ 39.40 | $ 44.06 | |
| May 8, 2024 | $ 1.04 | $ 42.77 | $ 42.43 | |
| Feb 28, 2024 | $ 0.88 | $ 55.44 | $ 46.57 | |
| Nov 8, 2023 | $ 1.15 | $ 46.01 | $ 52.41 | |
| Aug 8, 2023 | $ 0.65 | $ 63.08 | $ 62.21 | |
| May 9, 2023 | $ 0.62 | $ 36.42 | $ 41.19 | |
| Feb 28, 2023 | $ 0.73 | $ 32.46 | $ 36.56 | |
| Nov 7, 2022 | $ 0.38 | $ 29.76 | $ 27.28 | |
| Aug 8, 2022 | $ 0.39 | $ 36.76 | $ 32.06 | |
| May 9, 2022 | $ 0.47 | $ 32.71 | $ 34.00 | |
| Mar 10, 2022 | $ 0.42 | $ 30.10 | $ 34.30 |
Amphastar Pharmaceuticals released its most recent earnings reports in November 2026, August 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Amphastar Pharmaceuticals beat analysts’ expectations during the last earnings period by
